Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome

  • Domenica Scumaci
  • , Antonio Oliva
  • , Antonio Concolino
  • , Antonio Curcio
  • , Claudia Vincenza Fiumara
  • , Laura Tammè
  • , Oscar Campuzano
  • , Vincenzo Lorenzo Pascali
  • , Monica Coll
  • , Anna Iglesias
  • , Paola Berne
  • , Gavino Casu
  • , Erika Olivo
  • , Francesco Ausania
  • , Pietrantonio Ricci
  • , Ciro Indolfi
  • , Josep Brugada
  • , Ramon Brugada
  • , Giovanni Cuda

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: The Brugada syndrome (BrS) is a severe inherited cardiac disorder. Given the high genetic and phenotypic heterogeneity of this disease, three different “omics” approaches are integrated in a synergic way to elucidate the molecular mechanisms underlying the pathophysiology of BrS as well as for identifying reliable diagnostic/prognostic markers. Experimental design: The profiling of plasma Proteome and MiRNome is perfomed in a cohort of Brugada patients that were preliminary subjected to genomic analysis to assess a peculiar gene mutation profile. Results: The integrated analysis of “omics” data unveiled a cooperative activity of mutated genes, deregulated miRNAs and proteins in orchestrating transcriptional and post-translational events that are critical determining factors for the development of the Brugada pattern. Conclusions and clinical relevance: This study provides the basis to shed light on the specific molecular fingerprints underlying BrS development and to gain further insights on the pathogenesis of this life-threatening cardiac disease.
Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalProteomics - Clinical Applications
Volume12
DOIs
Publication statusPublished - 2018

Keywords

  • Clinical Biochemistry
  • MiRNA
  • brugada syndrome
  • genomics
  • personalized medicine
  • proteomics
  • reactive oxygen species

Fingerprint

Dive into the research topics of 'Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome'. Together they form a unique fingerprint.

Cite this